NEW PERSPECTIVES ON THE ACTIONS OF SULPHONYLUREAS AND HYPERGLYCEMIC SULFONAMIDES ON THE PANCREATIC B-CELL

Peter Flatt, O Shibier, J Szecowka, PO Berggren

Research output: Contribution to journalArticle

Abstract

Sulphonylureas and the hyperglycaemic sulphonamide diazoxide are commonly employed in the therapy of non-insulin-dependent (Type 2) diabetes mellitus and insulinoma, respectively. Stimulatory effects of sulphonylureas on insulin secretion and the inhibitory action of diazoxide are thought to be primarily mediated through modulation of the activity of ATP-sensitive K+ channels (K+-ATP channels) in the beta-cell plasma membrane. Certain sulphonylureas are known to be internalised by the pancreatic B-cell. Recent studies suggest that these drugs and diazoxide can influence insulin secretion from electropermeabilised beta-cells in which K+-ATP channels and other plasma membrane ion channels are inoperative. This observation suggests that sulphonylureas and diazoxide interact with intracellular sites in the pancreatic B-cell which are directly involved in the regulation of the final stages of exocytosis.
LanguageEnglish
Pages157-162
JournalDiabetes and Metabolism
Volume20
Issue number2
Publication statusPublished - Mar 1994

Fingerprint

Diazoxide
Sulfonamides
Insulin-Secreting Cells
Adenosine Triphosphate
Cell Membrane
Ion Channels
Insulin
Insulinoma
Exocytosis
Type 2 Diabetes Mellitus
Pharmaceutical Preparations

Cite this

@article{31345962dbdd45f0bd835fbc784f9ec8,
title = "NEW PERSPECTIVES ON THE ACTIONS OF SULPHONYLUREAS AND HYPERGLYCEMIC SULFONAMIDES ON THE PANCREATIC B-CELL",
abstract = "Sulphonylureas and the hyperglycaemic sulphonamide diazoxide are commonly employed in the therapy of non-insulin-dependent (Type 2) diabetes mellitus and insulinoma, respectively. Stimulatory effects of sulphonylureas on insulin secretion and the inhibitory action of diazoxide are thought to be primarily mediated through modulation of the activity of ATP-sensitive K+ channels (K+-ATP channels) in the beta-cell plasma membrane. Certain sulphonylureas are known to be internalised by the pancreatic B-cell. Recent studies suggest that these drugs and diazoxide can influence insulin secretion from electropermeabilised beta-cells in which K+-ATP channels and other plasma membrane ion channels are inoperative. This observation suggests that sulphonylureas and diazoxide interact with intracellular sites in the pancreatic B-cell which are directly involved in the regulation of the final stages of exocytosis.",
author = "Peter Flatt and O Shibier and J Szecowka and PO Berggren",
note = "Post-EASD Symposium on Islet Metabolism and Physiopathology, ISTANBUL, TURKEY, SEP 10-12, 1993",
year = "1994",
month = "3",
language = "English",
volume = "20",
pages = "157--162",
journal = "Diabetes and Metabolism",
issn = "1262-3636",
publisher = "Elsevier",
number = "2",

}

NEW PERSPECTIVES ON THE ACTIONS OF SULPHONYLUREAS AND HYPERGLYCEMIC SULFONAMIDES ON THE PANCREATIC B-CELL. / Flatt, Peter; Shibier, O; Szecowka, J; Berggren, PO.

In: Diabetes and Metabolism, Vol. 20, No. 2, 03.1994, p. 157-162.

Research output: Contribution to journalArticle

TY - JOUR

T1 - NEW PERSPECTIVES ON THE ACTIONS OF SULPHONYLUREAS AND HYPERGLYCEMIC SULFONAMIDES ON THE PANCREATIC B-CELL

AU - Flatt, Peter

AU - Shibier, O

AU - Szecowka, J

AU - Berggren, PO

N1 - Post-EASD Symposium on Islet Metabolism and Physiopathology, ISTANBUL, TURKEY, SEP 10-12, 1993

PY - 1994/3

Y1 - 1994/3

N2 - Sulphonylureas and the hyperglycaemic sulphonamide diazoxide are commonly employed in the therapy of non-insulin-dependent (Type 2) diabetes mellitus and insulinoma, respectively. Stimulatory effects of sulphonylureas on insulin secretion and the inhibitory action of diazoxide are thought to be primarily mediated through modulation of the activity of ATP-sensitive K+ channels (K+-ATP channels) in the beta-cell plasma membrane. Certain sulphonylureas are known to be internalised by the pancreatic B-cell. Recent studies suggest that these drugs and diazoxide can influence insulin secretion from electropermeabilised beta-cells in which K+-ATP channels and other plasma membrane ion channels are inoperative. This observation suggests that sulphonylureas and diazoxide interact with intracellular sites in the pancreatic B-cell which are directly involved in the regulation of the final stages of exocytosis.

AB - Sulphonylureas and the hyperglycaemic sulphonamide diazoxide are commonly employed in the therapy of non-insulin-dependent (Type 2) diabetes mellitus and insulinoma, respectively. Stimulatory effects of sulphonylureas on insulin secretion and the inhibitory action of diazoxide are thought to be primarily mediated through modulation of the activity of ATP-sensitive K+ channels (K+-ATP channels) in the beta-cell plasma membrane. Certain sulphonylureas are known to be internalised by the pancreatic B-cell. Recent studies suggest that these drugs and diazoxide can influence insulin secretion from electropermeabilised beta-cells in which K+-ATP channels and other plasma membrane ion channels are inoperative. This observation suggests that sulphonylureas and diazoxide interact with intracellular sites in the pancreatic B-cell which are directly involved in the regulation of the final stages of exocytosis.

M3 - Article

VL - 20

SP - 157

EP - 162

JO - Diabetes and Metabolism

T2 - Diabetes and Metabolism

JF - Diabetes and Metabolism

SN - 1262-3636

IS - 2

ER -